Sustained release donepezil loaded PLGA microspheres for injection: Preparation, in vitro and in vivo study

Asian Journal of Pharmaceutical Sciences

Volumn 10, Issue 5, 2015, Pages 405-414

  Guo, Wenjia ^a   Quan, Peng ^a   Fang, Liang ^a   Cun, Dongmei ^a   Yang, Mingshi ^a,b  

^a SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Donepezil; In vitro and in vivo correlation; Microspheres; PLGA; Sustained release

Indexed keywords

DONEPEZIL; MICROSPHERE; POLYGLACTIN;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG BLOOD LEVEL; DRUG METABOLISM; EMULSION; ENCAPSULATION; EVAPORATION; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PARTICLE SIZE; POROSITY; RAT; SCANNING ELECTRON MICROSCOPY; SUSTAINED DRUG RELEASE; X RAY DIFFRACTION;

EID: 84944155655     PISSN: 18180876     EISSN: 2221285X     Source Type: Journal    
DOI: 10.1016/j.ajps.2015.06.001     Document Type: Article

References (24)

1. Cummings J.L. Alzheimer's disease. NEJM 2004, 351(1):56-67.
2. Alzheimer's Association Alzheimer's disease facts and figures. Alzheimers Dement 2012, 8(2):131-168.
3. Ballard C., Gauthier S., Corbett A., et al. Alzheimer's disease. Lancet 2011, 377(9770):1019-1031.
4. Ritchie C.W., Ames D., Clayton T., et al. Meta analysis of randomized trials of the efficacy and safety of donepezil, galantamine, and rivastigmine for the treatment of Alzheimer's disease. Am J Geriatr Psychiatry 2004, 12(4):358-369.
5. Varde N.K., Pack D.W. Microshpheres for controlled release drug delivery. Expert Opin Biol Ther 2004, 4(1):35-51.
6. Zhang P., Chen L., Gu W., et al. In vitro and in vivo evaluation of donepezil-sustained release microparticles for the treatment of Alzheimer's disease. Biomaterials 2007, 28(10):1882-1888.
7. Xie M., Zhou L., Hu T., et al. Intratumoral delivery of paclitaxel-loaded poly(lactic-co-glycolic acid) microspheres for Hep-2 laryngeal squamous cell carcinoma xenografts. Anticancer Drugs 2007, 18(4):459-466.
8. Hickey T., Kreutzer D., Burgess D.J., et al. Dexamethasone/PLGA microspheres for continuous delivery of an anti-inflammatory drug for implantable medical devices. Biomaterials 2002, 23(7):1649-1656.
9. Sun L., Cun D.M., Yuan B., et al. Formulation and in vitro/in vivo correlation of a drug-in-adhesive transdermal patch containing azasetron. J Pharm Sci 2012, 101(12):4540-4548.
10. Liu N., Zhang Y., Cun D., et al. Effect of backing films on the transdermal delivery of donepezil from patches. AAPS PharmSciTech 2014, 15(6):1569-1573.
11. Jeong Y.I., Song J.G., Kang S.S., et al. Preparation of poly(DL-lactide-co-glycolide) microspheres encapsulating all-trans retinoic acid. Int J Pharm 2003, 259(1-2):79-91.
12. Lee S.C., Oh J.T., Jang M.H., et al. Quantitative analysis of polyvinyl alcohol on the surface of poly(D, L-lactide-co-glycolide) microparticles prepared by solvent evaporation method: effect of particle size and PVA concentration. J Control Release 1999, 59(2):123-132.
13. Ogawa Y., Yakamoto M., Okada H., et al. A new technique to efficiently entrap leuprolide acetate into microcapsules of polylactic acid or Copoly(lactic/glycolic) acid. Chem Pharm Bull (Tokyo) 1988, 36(3):1095-1103.
14. Ogawa Y., Yamamoto M., Takada S., et al. Controlled release of leuprolide acetate from polylactic acid or copoly (lactic/glycolic) acid microcapsules: influence of molecular weight and copolymer ratio of polymer. Chem Pharm Bull (Tokyo) 1988, 36(4):1502-1507.
15. Heya T., Okada H., Tanigawara Y., et al. Effects of counteranion of TRH and loading amount on control of TRH release from copoly (dl-lactic/glycolic acid) microspheres prepared by an in-water drying method. Int J Pharm 1991, 69(1):69-75.
16. Okada H., Yamamoto M., Heya T., et al. Drug delivery using biodegradable microspheres. J Control Release 1994, 28(1-3):121-129.
17. Okada H. One- and three-month release injectable microspheres of the LH-RH superagonist leuprorelin acetate. Adv Drug Deliv Rev 1997, 28(1):43-70.
18. Rouse J.J., Mohamed F., van der Walle C.F. Physical ageing and thermal analysis of PLGA microspheres encapsulating protein or DNA. Int J Pharm 2007, 339(1-2):112-120.
19. Mauduit J., Bukhb N., Vert M. Gentamycin/poly (lactic acid) blends aimed at sustained release local antibiotic therapy administered per-operatively. I. The case of gentamycin base and gentamycin sulfate in poly (DL-lactic acid) oligomers. J Control Release 1993, 23(3):209-220.
20. Ritger P.L., Peppas N.A. A simple equation for description of solute release I. Fickian and non-Fickian release from non-swellable devices in the form of slabs, spheres, cylinders or discs. J Control Release 1987, 5(1):23-36.
21. Jójárt I., Kása P., Kelemen A., et al. Study of the compressibility of chewing gum and its applicability as an oral drug delivery system. Pharm Dev Technol 2015, 12:1-7.
22. Papadopoulou V., Kosmidis K., Vlachou M., et al. On the use of the Weibull function for the discernment of drug release mechanisms. Int J Pharm 2006, 309(1-2):44-50.
23. Wischke C., Schwendeman S.P. Principles of encapsulating hydrophobic drugs in PLA/PLGA microparticles. Int J Pharm 2008, 364(2):298-327.
24. Liggins R.T., Burt H.M. Paclitaxel loaded poly(l-lactic acid) microspheres: properties of microspheres made with low molecular weight polymers. Int J Pharm 2001, 222(1):19-33.